Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
21.34
-0.02 (-0.09%)
At close: Dec 5, 2025, 4:00 PM EST
21.52
+0.18 (0.84%)
After-hours: Dec 5, 2025, 7:30 PM EST

Avadel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2,0911,013----
Upgrade
Enterprise Value
2,037985----
Upgrade
Last Close Price
21.3410.51----
Upgrade
Forward PE
30.87200.19----
Upgrade
PS Ratio
8.305.99----
Upgrade
PB Ratio
21.1213.71----
Upgrade
P/TBV Ratio
25.6917.76----
Upgrade
EV/Sales Ratio
8.205.83----
Upgrade
Debt / Equity Ratio
0.380.530.41-6.201.850.80
Upgrade
Debt / EBITDA Ratio
10.27-----
Upgrade
Debt / FCF Ratio
1.09-----
Upgrade
Asset Turnover
1.391.030.19--0.10
Upgrade
Inventory Turnover
0.631.00----
Upgrade
Quick Ratio
2.152.213.181.778.9917.30
Upgrade
Current Ratio
2.762.753.641.819.1717.44
Upgrade
Return on Equity (ROE)
-0.32%-60.44%-481.35%-481.49%-64.30%10.56%
Upgrade
Return on Assets (ROA)
-0.34%-16.11%-57.92%-31.32%-19.14%-9.90%
Upgrade
Return on Capital (ROIC)
-0.49%-22.41%-73.72%-35.73%-20.73%-11.64%
Upgrade
Return on Capital Employed (ROCE)
-0.70%-36.70%-107.80%-123.70%-37.80%-12.40%
Upgrade
Earnings Yield
-0.01%-4.82%----
Upgrade
FCF Yield
1.64%-4.63%----
Upgrade
Buyback Yield / Dilution
-3.42%-18.67%-33.41%-2.66%-6.54%-46.89%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.